US1280302027 - Common Stock

**CALM** gets a fundamental rating of **7** out of 10. The analysis compared the fundamentals against 93 industry peers in the **Food Products** industry. Both the health and profitability get an excellent rating, making **CALM** a very profitable company, without any liquidiy or solvency issues. **CALM** has a valuation in line with the averages, but it does not seem to be growing.

In the past 5 years **CALM** always reported a positive cash flow from operatings.

Looking at the **Return On Equity**, with a value of **15.98%**, **CALM** belongs to the top of the industry, outperforming **83.70%** of the companies in the same industry.

With an excellent **Return On Invested Capital** value of **12.80%**, **CALM** belongs to the best of the industry, outperforming **92.39%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 12.91% | ||

ROE | 15.98% | ||

ROIC | 12.8% |

ROA(3y)16.08%

ROA(5y)10.89%

ROE(3y)19.76%

ROE(5y)13.32%

ROIC(3y)N/A

ROIC(5y)N/A

The **Operating Margin** of **CALM** (**13.30%**) is better than **85.87%** of its industry peers.

Looking at the **Gross Margin**, with a value of **23.30%**, **CALM** is in line with its industry, outperforming **58.70%** of the companies in the same industry.

In the last couple of years the **Gross Margin** of **CALM** has grown nicely.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 13.3% | ||

PM (TTM) | 11.6% | ||

GM | 23.3% |

OM growth 3Y303.61%

OM growth 5Y20.45%

PM growth 3Y160.6%

PM growth 5Y23.53%

GM growth 3Y41.22%

GM growth 5Y9.63%

The number of shares outstanding for **CALM** has been increased compared to 5 years ago.

There is no outstanding debt for **CALM**. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

An Altman-Z score of **7.47** indicates that **CALM** is not in any danger for bankruptcy at the moment.

There is no outstanding debt for **CALM**. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0 | ||

Debt/FCF | 0 | ||

Altman-Z | 7.47 |

ROIC/WACC1.4

WACC9.13%

With an excellent **Quick ratio** value of **4.40**, **CALM** belongs to the best of the industry, outperforming **96.74%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 5.65 | ||

Quick Ratio | 4.4 |

The **Earnings Per Share** has been growing by **39.31%** on average over the past years. This is a very strong growth

EPS 1Y (TTM)-67.7%

EPS 3Y247.53%

EPS 5Y39.31%

EPS Q2Q%-64.2%

Revenue 1Y (TTM)-22.17%

Revenue growth 3Y32.53%

Revenue growth 5Y15.92%

Sales Q2Q%-29.52%

EPS Next Y-69.33%

EPS Next 2Y-61.18%

EPS Next 3Y-47.6%

EPS Next 5YN/A

Revenue Next Year-25.58%

Revenue Next 2Y-19.98%

Revenue Next 3Y-12.9%

Revenue Next 5YN/A

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

Based on the **Price/Earnings** ratio of **11.72**, the valuation of **CALM** can be described as reasonable.

The average S&P500 **Price/Earnings** ratio is at **28.24**. **CALM** is valued rather cheaply when compared to this.

A **Price/Forward Earnings** ratio of **25.08** indicates a quite expensive valuation of **CALM**.

The rest of the industry has a similar **Price/Forward Earnings** ratio as **CALM**.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 11.72 | ||

Fwd PE | 25.08 |

Based on the **Enterprise Value to EBITDA** ratio, **CALM** is valued cheaply inside the industry as 92.39% of the companies are valued more expensively.

Based on the **Price/Free Cash Flow** ratio, **CALM** is valued a bit cheaper than the industry average as 78.26% of the companies are valued more expensively.

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | 11.62 | ||

EV/EBITDA | 4.7 |

PEG (NY)N/A

PEG (5Y)0.3

EPS Next 2Y-61.18%

EPS Next 3Y-47.6%

Compared to an average industry **Dividend Yield** of **3.67**, **CALM** pays a better dividend. On top of this **CALM** pays more dividend than 97.83% of the companies listed in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 6.8% |

Dividend Growth(5Y)N/A

Div Incr Years2

Div Non Decr Years2

DP54.68%

EPS Next 2Y-61.18%

EPS Next 3Y-47.6%

**CAL-MAINE FOODS INC**

NASDAQ:CALM (6/12/2024, 1:44:48 PM)

**58.7**

**+0.13 (+0.22%) **

Chartmill FA Rating

GICS SectorConsumer Staples

GICS IndustryGroupFood, Beverage & Tobacco

GICS IndustryFood Products

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap2.88B

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 6.8% |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 11.72 | ||

Fwd PE | 25.08 | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)0.3

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 12.91% | ||

ROE | 15.98% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | 13.3% | ||

PM (TTM) | 11.6% | ||

GM | 23.3% | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover1.11

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | 5.65 | ||

Quick Ratio | 4.4 | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)-67.7%

EPS 3Y247.53%

EPS 5Y

EPS Q2Q%

EPS Next Y-69.33%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)-22.17%

Revenue growth 3Y32.53%

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y